Fig. 4.

In vivo antitumor effects of the HOCl-CDS hydrogel. a Schematic diagram of HOCl-CDS hydrogel treatment in mice bearing subcutaneous B16–F10 tumors. b Representative photographs of tumors. c Tumor growth curves. Data are presented as means ± SEM (n = 5–6). d Representative bioluminescence images of mice bearing B16-LUC tumors. e The survival curves of tumor-bearing mice (n = 12). f Weight of mice up to 21 d after treatment. Data are presented as means ± SEM (n = 7). g Hemanalysis on day 8 after treatment. Data are presented as means ± SEM (n = 5). h Micrographs of H&E staining of major organs; the scale bar indicates 50 μm.